Related by context. Frequent words. (Click for all words.) 61 Factor VIIa 59 Panzem R 58 proteasome inhibitor 57 Shigamabs ® 57 R sorafenib tablets 57 liposomal formulation 57 novel anticancer 56 selective inhibitor 56 novel orally administered 56 selectively inhibits 56 CCX# 55 HCV protease inhibitor 55 mTOR inhibitor 55 epothilone 55 PEG SN# 55 KRN# 54 anticancer compound 54 TLR9 agonist 53 Drug Candidate 53 Hsp# inhibitor 53 HCV protease 53 GRN#L 53 MORAb 53 topical anti infective 53 MEK inhibitor 53 Pivotal Phase III 52 humanized monoclonal antibody 52 partial agonist 52 atacicept 52 generation antisense 52 Clevudine 52 PSN# [002] 52 application sNDA 52 Carfilzomib 52 CORT # 52 Inc. Nasdaq IMGN 52 metastatic hormone refractory 52 kinesin spindle protein 51 ARC# [001] 51 AACR NCI EORTC 51 antisense drug 51 BMN 51 rheumatoid arthritis psoriasis 51 Small Molecule 51 Guanilib 51 investigational oral 51 subcutaneous formulation 51 pertuzumab 51 Phenoptin 51 non nucleoside polymerase 51 ixabepilone 51 BiTE antibody 51 Phase III Clinical Trial 51 Preclinical Data 51 Amrubicin 51 injectable formulation 50 Application BLA 50 IMC #B 50 inflammation autoimmune diseases 50 Bicifadine 50 Icatibant 50 tezampanel 50 Metastatic Melanoma 50 Vilazodone 50 multiple myeloma MM 50 Clinical Oncology ASCO Annual 50 GLPG# 50 proteasome inhibitors 50 Nexavar ® 50 R bortezomib 50 PARP inhibitor 50 induces apoptosis 50 OX1 50 Phase 2b clinical trials 50 Antisense 50 ATL# [001] 50 BEMA TM Fentanyl 50 OXi# 50 Traficet EN 50 FDA Accepts 49 IND enabling 49 IIa trial 49 RGB # 49 ENMD 49 phase IIa clinical 49 Initiate Phase 49 Recombinant Human 49 ALN TTR# 49 elotuzumab 49 Belinostat 49 administered subcutaneously 49 AP# [003] 49 PXD# 49 Solzira 49 SAR# [004] 49 FLT3 49 Cloretazine R VNP#M 49 INCB# [001] 49 EORTC NCI AACR 49 Omigard 49 phase IIb clinical